Down-regulation of Bcl-2, activation of caspases, and involvement of reactive oxygen species in 6-hydroxydopamine-induced thymocyte apoptosis

NeuroImmunoModulation

Volumn 10, Issue 6, 2002, Pages 328-336

  Tsao, Chiung Wen ^a   Cheng, Juei Tang ^b   Lin, Yee Shin ^b  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

6 Hydroxydopamine; Apoptosis; Bcl 2; Caspase; Reactive oxygen species; Thymocytes

Indexed keywords

CASPASE; CASPASE INHIBITOR; COPPER; DESIPRAMINE; DNA FRAGMENT; IODIDE; OXIDOPAMINE; PROPIDIUM IODIDE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; ZINC;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CATECHOLAMINE UPTAKE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; ENZYME ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SPACE; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STAINING; THYMOCYTE;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CASPASES; CELLS, CULTURED; DOWN-REGULATION; ENZYME INHIBITORS; FEMALE; MALE; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0042573936     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071473     Document Type: Article

References (45)

1. Felten DL, Felten SY, Bellinger DL, Carlson SL, Ackerman KD, Madden KS, Olschowki JA, Livnat S: Noradrenergic sympathetic neural interactions with the immune system: Structure and function. Immunol Rev 1987;100:225-260.
2. Madden KS, Livnat S: Catecholamine action and immunologic reactivity; in Ader R, Felten DL, Cohen N (eds): Psychoneuroimmunology, ed 2. San Diego, Academic Press, 1991, pp 283-310.
3. Leposavic G, Micic M, Ugresic N, Bogojevic M, Isakovic K: Components of sympathetic innervation of the rat thymus during late fetal and postnatal development: Histofluorescence and biochemical study. Thymus 1992;19:77-87.
4. Kostrzewa RM, Jacobowitz DM: Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev 1974;26:199-288.
5. Baumgarten HG, Zimmermann B: Neurotoxic phenylalkylamines and indolealkylamines; in Herken H, Hucho F (eds): Handbook of Experimental Pharmacology: Selective Neurotoxicity. New York, Springer, vol 102, 1992, pp 225-291.
6. Madden KS, Felten SY, Felten DL, Sundaresan PR, Livnat S: Sympathetic neural modulation of the immune system. I. Depression of T cell immunity in vivo and in vitro following chemical sympathectomy. Brain Behav Immun 1989;3:72-89.
7. Kruszewska B, Felten SY, Moynihan JA: Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. J Immunol 1995;155:4613-4620.
8. Hall NR, McClure JE, Hu SK, Tare NS, Seals CM, Goldstein AL: Effects of 6-hydroxydopamine upon primary and secondary thymus dependent immune responses. Immunopharmacology 1982;5:39-48.
9. Kendall MD, Al-Shawaf AA: Innervation of the rat thymus gland. Brain Behav Immun 1991;5:9-28.
10. Tsao CW, Cheng JT, Shen CL, Lin YS: 6-Hydroxydopamine induces thymocyte apoptosis in mice. J Neuroimmunol 1996;65:91-95.
11. Fadeel B, Ahlin A, Henter JI, Orrenius S, Hampton MB. Involvement of caspases in neutrophil apoptosis: Regulation by reactive oxygen species. Blood 1998;92:4808-4818.
12. Hildeman DA, Mitchell T, Teague TK, Henson P, Day BJ, Kappler J, Marrack PC: Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 1999;10:735-744.
13. 2), caspase-3, and nuclear factor kappa-B (NF-κB), p53, c-Jun transcription factors. Biol Pharmacol 2002;63:677-688.
14. Kroemer G, Zamzami N, Susin SA: Mitochondrial control of apoptosis. Immunol Today 1997;18:44-51.
15. Reed JC: Double identity for proteins of the Bcl-2 family. Nature 1997;387:773-776.
16. Depraetere V, Golstein P: Dismantling in cell death: Molecular mechanisms and relationship to caspase activation. Scand J Immunol 1998;47:523-531.
17. Thornberry NA, Lazebnik Y: Caspases: Enemies within. Science 1998;281:1312-1316.
18. Sander B, Andersson J, Andersson U: Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol Rev 1991;119:65-93.
19. Hogquist KA, Nett MA, Unanue ER, Chaplin DD: Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 1991;88:8485-8489.
20. Lin YS, Lei HY, Low TL, Shen CL, Chou LJ, Jan MS: In vivo induction of apoptosis in immature thymocytes by staphylococcal enterotoxin B. J Immunol 1992;149:1156-1163.
21. Ormerod MG: Analysis of DNA: General methods; in Ormerod MG (ed): Flow Cytometry: A Practical Approach. New York, Oxford University Press, 1990, p 75.
22. Walkinshaw G, Waters CM: Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 1994;63:975-987.
23. Blum D, Wu Y, Nissou MF, Arnaud S, Benabid AL, Verna JM: p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells. Brain Res 1997;751:139-142.
24. Takai N, Nakanishi H, Tanabe K, Nishioku T, Sugiyama T, Fujiwara M, Yamamoto K: Involvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine. J Neurosci Res 1998;54:214-222.
25. Jeon BS, Kholodilov NG, Oo TF, Kim SY, Tomaselli KJ, Srinivasan A, Stefanis L, Burke RE: Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra. J Neurochem 1999;73:322-333.
26. Bergquist J, Tarkowski A, Ekman R, Ewing A: Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci USA 1994;91:12912-12916.
27. 3H]-dopamine uptake by human lymphocytes: Correlates with serotonin transporter activity. Pharmacology 1994;48:320-327.
28. Faraj BA, Olkowski ZL, Jackson RT: A cocaine-sensitive active dopamine transport in human lymphocytes. Biochem Pharmacol 1995;50:1007-1014.
29. Amenta F, Bronzetti E, Cantalamessa F, El-Assouad D, Felici L, Ricci A, Tayebati SK: Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes. J Neuroimmunol 2001;117:133-142.
30. Josefsson E, Bergquist J, Ekman R, Tarkowski A: Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 1996;88:140-146.
31. Tsao CW, Lin YS, Cheng JT: Inhibition of immune cell proliferation with haloperidol and relationship of tyrosine hydroxylase expression to immune cell growth. Life Sci 1998;62:PL335-344.
32. Dipasquale B, Marini AM, Youle RJ: Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem Biophys Res Commun 1991;181:1442-1448.
33. +) in ventral mesencephalic-striatal co-culture in rat. Neurosci Lett 1994;170:191-194.
34. Zhang J, Pieper A, Snyder SH: Poly(ADP-ribose) synthetase activation: An early indicator of neurotoxic DNA damage. J Neurochem 1995;65:1411-1414.
35. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001;53:135-159.
36. Kumar R, Agarwal AK, Seth PK: Free radical-generated neurotoxicity of 6-hydroxydopamine. J Neurochem 1995;64:1703-1707.
37. +-induced dopaminergic neuronal cell death: Role of caspases, ROS, and JNK. J Neurosci Res 1999;57:86-94.
38. Henkart PA: ICE family proteases: Mediators of all apoptotic cell death? Immunity 1996;4:195-201.
39. Rao L, White E: Bcl-2 and the ICE family of apoptotic regulators: Making a connection. Curr Opin Genet Dev 1997;7:52-58.
40. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW: A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997;272:17907-17911.
41. Petit PX, Susin SA, Zamzami N, Mignotte B, Kroemer G: Mitochondria and programmed cell death: Back to the future. FEBS Lett 1996;396:7-13.
42. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH: Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 1993;90:9808-9812.
43. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P: Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995;15:961-973.
44. +) and nitric oxide simultaneously causes cyclosporin A-sensitive mitochondrial calcium efflux and depolarisation. Biochem Pharmacol 1996;51:267-273.
45. +, apoptosis induced by 6-OHDA in PC12 cells is independent of mitochondrial inhibition. Neurosci Lett 1996;221:69-71.